Article
TheraLight received clearance from the U.S. Food and Drug Administrationto market its UV120-2 UVA/UUVB Phototherapy System for the treatment ofpsoriasis, vitiligo, atopic dermatitis and seborrheic dermatitis.
Clinical Pearls for Vitiligo and Pigmentation Complexities: Part 3
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Which Tax Treatment Is Best for Your Dermatology Practice?
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Insights into the Association Between Pruritus and Liver Disease
Addressing Challenging Cases of Acne: Part 3